Dana P. Goldman, PhD

This study assesses the preferences of patients with cystic fibrosis for treatments that differ in the mode of administration.

This paper explores the economic incentives that oncologists face when deciding between oral and intravenous oncolytics and their impact on prescribing behavior.

This study characterizes the role of specialty drug utilization in aggregate private sector healthcare spending in the United States from 2000 to 2009.